Results 121 to 130 of about 161,071 (201)

Interleukin-1 Receptor Antagonist as a Potential Mediator Linking Psoriasis and Non-Alcoholic Fatty Liver Disease: Insights From Mendelian Randomization and Experimental Evidence. [PDF]

Clin Cosmet Investig Dermatol
Shuai C, Cheung S, Zhang L, Cao H, Yuan Y, Ge Q, Wang Y, Li X, Zheng J, Xue F.   +9 more
europepmc   +1 more source

Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy. [PDF]

Biomed Res Int, 2022
Liao X, Xiao Y, Elbelt U, Weylandt KH, Li K, Deng J, Zeng N, Xue C.   +7 more
europepmc   +1 more source

Varying levels of interleukin 1 receptor antagonist (<i>Il1rn</i>) gene expression affect circulating leptin concentrations and fat distribution. [PDF]

Genom Psychiatry
Wong ML, Mastronardi C, Paz-Filho G, Simeonovic C, Licinio J.   +4 more
europepmc   +1 more source

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice. [PDF]

Int J Mol Sci, 2022
Ku EJ, Kim BR, Lee JI, Lee YK, Oh TJ, Jang HC, Choi SH.   +6 more
europepmc   +1 more source

Correction: Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3. [PDF]

Stem Cell Res Ther
Song J, Han Y, Chen Y, Cheng L, Xiao J, Li A, Kong D, Jiang Y, Zheng C.   +8 more
europepmc   +1 more source

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. [PDF]

Lancet Rheumatol, 2022
Pfeifer J, Thurner B, Kessel C, Fadle N, Kheiroddin P, Regitz E, Hoffmann MC, Kos IA, Preuss KD, Fischer Y, Roemer K, Lohse S, Heyne K, Detemple MC, Fedlmeier M, Juenger H, Sauer H, Meyer S, Rohrer T, Wittkowski H, Becker SL, Masjosthusmann K, Bals R, Gerling S, Smola S, Bewarder M, Birk E, Keren A, Böhm M, Jakob A, Abdul-Khaliq H, Anton J, Kabesch M, Pino-Ramirez RM, Foell D, Thurner L.   +35 more
europepmc   +1 more source

The Activity of Protectin DX, 17 HDHA and Leukotriene B4 Is Correlated with Interleukin-1β (IL-1β) and Interleukin-1 Receptor Antagonist (IL-1Ra) in the Early Subacute Phase of Stroke. [PDF]

Int J Mol Sci
Kotlega D, Drozd A, Zembron-Lacny A, Morawin B, Ryterska K, Szczuko M.   +5 more
europepmc   +1 more source

Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3. [PDF]

Stem Cell Res Ther
Song J, Han Y, Chen Y, Cheng L, Xiao J, Li A, Kong D, Jiang Y, Zheng C.   +8 more
europepmc   +1 more source

The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion. [PDF]

Int J Mol Sci, 2021
Schneider L, Liu J, Zhang C, Azoitei A, Meessen S, Zheng X, Cremer C, Gorzelanny C, Kempe-Gonzales S, Brunner C, Wezel F, Bolenz C, Gunes C, John A.   +13 more
europepmc   +1 more source

Interleukin 1 Receptor Antagonist (IL-1ra) Production and Expression Dynamics in Mammary Glands After Lipopolysaccharide Infusion. [PDF]

Anim Sci J
Marufah NL, Nii T, Suzuki N, Jaisue J, Isobe N.   +4 more
europepmc   +1 more source